Rituximab-Induced Interstitial Lung Disease: Case Report and Literature Review
2011
Rituximab, a chimeric monoclonal antibody against CD20, very rarely causes lung toxicity. Toxicity may present as interstitial lung disease, alveolar hemorrhage and adult respiratory distress syndrome
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
16
Citations
NaN
KQI